Notably, SXR can reduce oxidative and inflammatory disorders in COVID-19 by activating Nrf2 and PPAR-γ (Umemoto and Fujiki, 2012; Tajiri et al., 2016). This evidence concerns the gene NR1I2 and COVID-19.